Semi-Annual Consolidated Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7270714

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
13,914,000,000 JPY
13,680,000,000 JPY
24,153,000,000 JPY
27,559,000,000 JPY
Depreciation
6,615,000,000 JPY
4,929,000,000 JPY
Amortization of goodwill
1,407,000,000 JPY
1,128,000,000 JPY
Interest and dividend income
-815,000,000 JPY
-763,000,000 JPY
Interest expenses
28,000,000 JPY
29,000,000 JPY
Decrease (increase) in trade receivables
4,780,000,000 JPY
-3,781,000,000 JPY
Decrease (increase) in inventories
-1,144,000,000 JPY
-3,175,000,000 JPY
Increase (decrease) in trade payables
-2,931,000,000 JPY
-1,390,000,000 JPY
Other, net
-771,000,000 JPY
76,000,000 JPY
Subtotal
17,951,000,000 JPY
25,986,000,000 JPY
Interest and dividends received
801,000,000 JPY
754,000,000 JPY
Interest paid
-34,000,000 JPY
-22,000,000 JPY
Income taxes paid
-7,471,000,000 JPY
-8,358,000,000 JPY
Net cash provided by (used in) operating activities
11,246,000,000 JPY
18,360,000,000 JPY
Cash flows from investing activities
Purchase of securities
-2,000,000,000 JPY
-4,000,000,000 JPY
Purchase of property, plant and equipment
-26,056,000,000 JPY
-12,756,000,000 JPY
Proceeds from sale of property, plant and equipment
22,000,000 JPY
5,000,000 JPY
Purchase of investment securities
-18,000,000 JPY
-220,000,000 JPY
Proceeds from sale of investment securities
959,000,000 JPY
531,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
JPY
-11,176,000,000 JPY
Other, net
138,000,000 JPY
-231,000,000 JPY
Net cash provided by (used in) investing activities
-18,415,000,000 JPY
-19,576,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
-12,000,000,000 JPY
Dividends paid
-7,505,000,000 JPY
-7,223,000,000 JPY
Net cash provided by (used in) financing activities
-7,768,000,000 JPY
-19,463,000,000 JPY
Other, net
-262,000,000 JPY
-239,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,220,000,000 JPY
890,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-13,717,000,000 JPY
-19,789,000,000 JPY
Cash and cash equivalents
45,973,000,000 JPY
59,690,000,000 JPY
79,480,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.